NCT05623787View on ClinicalTrials.gov

Diagnostic Value of Diffusion-weighted Magnetic Resonance in High-risk Colorectal and Appendiceal Neoplasms

NAActive, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2025

Conditions
Peritoneal CarcinomatosisPeritoneal MetastasesAppendix CancerAppendix NeoplasmColorectal Cancer
Interventions
DIAGNOSTIC_TEST

Whole-body diffusion-weighted magnetic resonance imaging

See arm description.

Trial Locations (2)

H1T 2M4

CIUSSS de l'Est-de-l'Île-de-Montréal, Montreal

G1R 2J6

CHU de Québec, Québec

All Listed Sponsors
collaborator

Ciusss de L'Est de l'Île de Montréal

OTHER

lead

Laval University

OTHER